Lee, Danner & Bass’s Genomic Health, Inc. GHDX Stock Holding History

Lee, Danner & Bass’s Portfolio GHDX Stock Details GHDX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	–	Sell	-3,000	Closed	-$203K	–	182
2019 Q3	$203K	Buy	+3,000	New	+$206K	0.02%	172
2019 Q2	–	Sell	-3,000	Closed	-$210K	–	178
2019 Q1	$210K	Buy	+3,000	New	+$222K	0.02%	166
2018 Q4	–	Sell	-3,000	Closed	-$211K	–	178
2018 Q3	$211K	Buy	+3,000	New	+$175K	0.02%	170

Lee, Danner & Bass's GHDX Position: Q4 2019 in Review

Lee, Danner & Bass sold out of Genomic Health, Inc. (GHDX) in Q4 2019, closing a stake of 3,000 shares — an estimated $203K sold.

Lee, Danner & Bass first reported a position in GHDX in Q3 2018 and held it in 3 quarters. The position peaked at $211K in Q3 2018. 0 funds tracked by Wall St. Rank hold GHDX as of Q4 2019.

Lee, Danner & Bass reported no remaining Genomic Health, Inc. position as of Q4 2019 after selling out during the quarter.
Lee, Danner & Bass sold 3,000 Genomic Health, Inc. shares in Q4 2019, an estimated $203K.
Lee, Danner & Bass first reported a position in Genomic Health, Inc. in Q3 2018 and held it in 3 quarters.
Lee, Danner & Bass's Genomic Health, Inc. position peaked at $211K in Q3 2018.
0 funds tracked by Wall St. Rank held Genomic Health, Inc. as of Q4 2019.

Based on Lee, Danner & Bass's 13F filing for Q4 2019, filed 13 Feb 2020.